Peppy vs. Core Peptides: laboratory testing and prescription care

Disclosure: Peppy Care publishes this comparison of its own service. Public information checked October 22, 2026; no firsthand product testing. Seller statements are attributed, not independently certified.

The Core Peptides website describes research peptides and blends, with products intended for laboratory use rather than human consumption. It identifies Vanguard Laboratory as a testing provider and describes that laboratory as A2LA-accredited. These are the seller’s public statements; this article does not independently audit the laboratory or authenticate individual certificates.

That distinction matters when a search for “best peptides” returns both research catalogs and healthcare services. The useful first question is the purpose of the purchase. Ordering material for a laboratory experiment and seeking treatment for a health condition require different evidence and responsibilities.

Accreditation concerns a laboratory and the activities within its accredited scope. It should not be read as approval of every product sold by a client, or as a finding that a peptide treats a particular condition. Likewise, a COA can report tests on submitted material without studying patient outcomes.

When reading a report, separate identity, measured quantity, purity, and any other reported tests. Check the laboratory, report date, sample identifier, and connection to the relevant batch. A percentage without the method and sample context cannot answer all those questions. Our guide to reading a COA explains this distinction without treating an analytical report as a prescription.

Under Peppy’s published policy, a licensed provider reviews a health intake and, if treatment is approved, sends a prescription to a licensed compounding pharmacy. That process adds an individual medical decision. It does not establish that every requested ingredient is available or appropriate.

The clinical question remains separate from the chemistry: what condition is being treated, what evidence supports the proposed medicine, and what alternatives could meet the need? FDA’s compounding guidance explains that compounded drugs are not FDA-approved. A pharmacy relationship should therefore prompt product-specific questions, not an assumption that compounded and approved medicines have identical evidence.

For a healthcare decision, ask who will assess you, which pharmacy would dispense, and who handles problems after treatment begins. The FDA’s online-pharmacy checklist emphasizes prescriptions, state licensure, and access to a licensed pharmacist. Verify those details for the actual provider and pharmacy involved.

Core Peptides’ testing statements and Peppy’s care process should not be collapsed into a single purity-score contest. A useful comparison records both analytical documentation and clinical accountability, then asks whether the proposed treatment is justified for the patient. Neither a seller’s certificate nor this comparison supplies that individualized judgment.